Anixa Biosciences Inc (ANIX) has 12 SEC Form 4 insider filings on record in the last 90 days. That includes 11 insider purchases totalling $189K. Most recent filing: Sept. 14, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 14, 2026 filed Sept. 10, 2026 | KUMAR AMIT Chief Executive Officer | +$8,250 | 3,000 | +0% | No | |
|
|
||||||
| Sept. 14, 2026 filed Sept. 10, 2026 | Titterton Lewis H jr Director | +$27,300 | 10,000 | +1% | No | |
|
|
||||||
| Sept. 11, 2026 filed Sept. 10, 2026 | KUMAR AMIT Chief Executive Officer | +$13,800 | 5,000 | +1% | No | |
|
|
||||||
| Aug. 3, 2026 filed July 31, 2026 | KUMAR AMIT Chief Executive Officer | +$17,350 | 5,000 | +1% | No | |
|
|
||||||
| July 29, 2026 filed July 27, 2026 | Baskies Arnold M Director | — | +572 | — | No | |
|
|
||||||
Showing the 5 most recent of 12 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free